Anterix Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-85.1% vs price
Base Case (Median)
-72.5% vs price
Bull Case (75th pct.)
-55.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $6.09 | -93.1% | High (40%) |
| PE Comparable | $57.76 | -34.9% | Medium (25%) |
| Graham Number | $33.25 | -62.5% | Low (10%) |
| EV/FCF | $15.62 | -82.4% | Medium (20%) |
Based on 4 out of 8 methods, ATEX appears overvalued at the current price of $88.68. The base case fair value of $24.43 implies 72.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.